CollPlant Biotechnologies (CLGN) Work In Process (2022 - 2025)
CollPlant Biotechnologies (CLGN) posted Work In Process of $283000.0 for Q4 2025, down 1.05% on a QoQ basis from $286000.0 in Q4 2024, and down 1.05% year-over-year from $286000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Work In Process (2022 - 2025) Analysis & Trends
CollPlant Biotechnologies' Work In Process history runs 4 years deep, the most recent figure standing at $283000.0 for Q4 2025.
- Quarterly Work In Process fell 1.05% year-over-year to $283000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283000.0 (down 1.05% YoY) and the FY2025 annual result came in at $283000.0, down 1.05% from the prior year.
- Work In Process was $283000.0 for Q4 2025 at CollPlant Biotechnologies, down from $286000.0 in the prior quarter.
- Across five years, Work In Process topped out at $881000.0 in Q4 2022 and bottomed at $173000.0 in Q4 2023.
- A 4-year average of $405750.0 and a median of $284500.0 in 2024 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process tumbled 80.36% — and 2024, when it soared 65.32%.
- CollPlant Biotechnologies' Work In Process stood at $881000.0 in 2022, then tumbled by 80.36% to $173000.0 in 2023, then surged by 65.32% to $286000.0 in 2024, then slipped by 1.05% to $283000.0 in 2025.
- Business Quant data shows CLGN's Work In Process at $283000.0 in Q4 2025, $286000.0 in Q4 2024, and $173000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 283,000.00 |
| Dec 31, 2024 | 286,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Dec 31, 2022 | 881,000.00 |